ReviewInternational endodontic journal2026
Redefining the Evolution of Pulpal Pathology: Inflammasomes as Central Integrative Hubs and Biological Switches Governing the Transition From Reversible to Irreversible Pulpal Inflammation Beyond Symptom-Based Classification.
Review in International endodontic journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe transition from reversible to irreversible pulpitis remains inadequately defined at the molecular level. Current classifications rely largely on clinical symptoms rather than objective biological determinants, limiting diagnostic precision and therapeutic decision-making.
objectivesTo integrate current experimental and translational evidence positioning inflammasomes as central molecular decision-making platforms in pulpal inflammation, and to propose a biologically grounded model in which inflammasome activation and supramolecular assembly define the threshold separating adaptive, reversible inflammation from irreversible pulpal damage, with direct clinical implications.
methodsA structured narrative review was conducted following a comprehensive literature search of PubMed/MEDLINE, Scopus, and Web of Science from inception to December 2025. Evidence derived from in vitro systems, in vivo animal models, and analyses of human inflamed pulpal tissues was synthesised to characterise inflammasome sensors, adaptor and effector components, regulatory checkpoints, downstream inflammatory outputs, and their relevance to pulpal disease progression.
resultsDental pulp cells express functional inflammasome sensors, including NLRP3, AIM2, and NLRP6, which respond to inflammatory, metabolic, and damage-associated signals. Inflammasome activation follows a stepwise process of transcriptional priming and threshold-dependent assembly. While NF-κB- and type I interferon-mediated priming is adaptive and potentially reversible, ASC speck formation represents a molecular commitment point leading to caspase-1 activation, gasdermin D cleavage, IL-1β/IL-18 maturation, and pyroptotic cell death. Mitochondrial dysfunction, cytosolic mtDNA release, sustained ion fluxes, P2X7 signalling, and loss of endogenous inhibitory regulators further amplify inflammasome activity, promoting self-sustaining inflammatory circuits and progressive tissue breakdown.
conclusionsPulpal inflammation should be understood not as a linear increase in microbial burden, but as a biological transition driven by inflammasome checkpoint failure. Irreversible ASC speck formation functions as a commitment switch that sustains caspase-1 activation, gasdermin D-mediated pyroptosis, and self-amplifying IL-1β/IL-18 signalling. Within the confined pulp environment, this feed-forward inflammatory circuitry promotes neurovascular dysregulation and severe pain, ultimately becoming uncoupled from the initiating insult and incompatible with tissue recovery. Recognising Inflammasome activation (ASC speck formation) as a point of no return may refine diagnostic paradigms and help redefine the biological limits of vital pulp therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.